Status:
UNKNOWN
Whiplash-associated Disorders - Needling Treatments Pilot Study
Lead Sponsor:
University of British Columbia
Conditions:
Whiplash Injury
Eligibility:
All Genders
19-75 years
Phase:
NA
Brief Summary
This pilot study is being conducted to provide proof of concept for three recently developed needling treatments, in the treatment of whiplash associated disorder type 2 (WAD-II). The investigators ai...
Detailed Description
Evidence shows that people who do not recover from whiplash symptoms within the acute phase (3 months post-injury) may continue to have neck pain and disability years later. The investigators hope to ...
Eligibility Criteria
Inclusion
- Between 19 and 75 years of age
- At least 12 months post-trauma
- Present with neck and upper back pain (with or without headaches) , matching criteria for WAD-II
- Presence of palpable painful points, a necessary indicator that a patient is suitable candidate for treatment
Exclusion
- Widespread pain
- History of pre-existing or comorbid chronic pain conditions
- Use of anti-coagulants (eg: Coumadin, Warfarin, other prescription anti-coagulants/blood thinners)
- Immune deficiency and/or use of immunosuppressants (especially those with splenectomy)
- Autoimmune disorders such as lupus or rheumatoid arthritis
- HIV, viral hepatitis and other blood borne communicable disease (for practitioner safety)
- Local infection around needle insertion site
- Fever or systemic infection (cold/flu)
- Pregnancy
- Unstable bleeding disorders
- Less than 6 months post-surgery
- Metal implants/screws in the gleno-humeral joint
- History of bacterial endocardititis
- Heart valve replacement
- Past history of any of the proposed needle treatments in the treatment of chronic pain disorders
- Needle-based treatment (including any of the treatments in this study, cortisone or botox injection, etc.) for the whiplash injury in the past 3 months
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2016
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01824810
Start Date
June 1 2013
End Date
March 1 2016
Last Update
August 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHANGEpain Clinic
Vancouver, British Columbia, Canada, V5Z3A4